文献速递产科母胎医学

有子痫前期史女性的血管生成生物标志物浓度及其与冠状动脉粥样硬化的关系:CPH-PRECIOUS研究结果

Angiogenic biomarker concentrations and their relation to coronary atherosclerosis in women with a history of preeclampsia: Findings from the CPH‐PRECIOUS study
RSS 订阅 · Acta Obstetricia et Gynecologica Scandinavica · 2026-10-26

该横断面研究纳入892名有子痫前期史的女性,评估CT评估的冠状动脉粥样硬化与循环血管生成生物标志物浓度的差异。存在冠状动脉粥样硬化者胎盘生长因子(PlGF)浓度显著更高,而可溶性fms样酪氨酸激酶-1(sFlt-1)浓度无差异;sFlt-1/PlGF比值更高与冠状动脉粥样硬化几率更低相关。

要点

  • 有子痫前期史女性中,CT评估存在冠状动脉粥样硬化者PlGF浓度显著更高。
  • sFlt-1浓度在有无冠状动脉粥样硬化者间无显著差异。
  • sFlt-1/PlGF比值更高与冠状动脉粥样硬化几率更低相关。

核心结论

  • 有子痫前期史的女性在指数妊娠多年后,若CT评估存在冠状动脉粥样硬化,其PlGF浓度显著更高,而sFlt-1浓度无差异。
  • 较高的sFlt-1/PlGF比值与较低的冠状动脉粥样硬化几率相关。

研究设计与样本

  • 横断面研究,纳入892名有子痫前期史、当前年龄35至55岁的女性,来自CPH-PRECIOUS队列。
  • 女性从丹麦首都地区1995年起所有分娩的临床数据库中识别。
  • 主要结局为根据CT评估的冠状动脉粥样硬化分组的循环血管生成生物标志物浓度差异。

主要发现

  • 距子痫前期妊娠的中位时间为12.5年(范围0–28年)。
  • 有冠状动脉粥样硬化者PlGF浓度为9.6 pg/mL(IQR 4.9–12.6),无冠状动脉粥样硬化者为7.4 pg/mL(IQR 3.9–11.3),p=0.001。
  • 有冠状动脉粥样硬化者sFlt-1/PlGF比值为4.2(IQR 3.1–6.3),无冠状动脉粥样硬化者为5.0(IQR 3.6–6.9),p=0.001。
  • sFlt-1浓度未见差异。
  • 较高的PlGF浓度与冠状动脉粥样硬化显著相关,但校正分析后关联减弱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study demonstrates that women with prior preeclampsia had significantly higher concentrations of PlGF when CT-assessed coronary atherosclerosis was present years following the index pregnancy, whereas no difference was found for concentrations of sFlt-1. Hence, a higher ratio of sFlt-1/PlGF was associated with lower odds for coronary atherosclerosis. Abstract Introduction Preeclampsia is known to be associated with a two- to fourfold elevated risk of developing cardiovascular disease in the first 15 years following pregnancy. In this cross-sectional study of 892 women with prior preeclampsia, we aimed to assess differences in circulating angiogenic biomarker concentrations according to CT-assessed coronary atherosclerosis in women up to 28 years after an index pregnancy complicated by preeclampsia. Material and Methods Women were identified from clinical databases consisting of data from all deliveries within the Capital Region of Denmark from 1995 onwards. Women with prior preeclampsia and a current age between 35 and 55 years were included from the CPH-PRECIOUS cohort. The primary outcome was differences in circulating angiogenic biomarkers according to CT-assessed coronary atherosclerosis. Results The median time since the pregnancy complicated by preeclampsia was 12.5 years (range: 0–28 years). PlGF concentrations were significantly higher in women with coronary atherosclerosis (9.6 pg/mL [IQR 4.9–12.6] vs. 7.4 pg/mL [IQR 3.9–11.3], p = 0.001), and subsequently a lower calculated sFlt-1/PlGF ratio (4.2 [IQR 3.1–6.3] vs. 5.0 [IQR 3.6–6.9], p = 0.001) was found. No differences in sFlt-1 concentrations were observed. Higher PlGF concentrations were significantly associated with coronary atherosclerosis; however, associations were attenuated in adjusted analysis. Conclusions This is the first large study to investigate long-term differences in circulating angiogenic biomarker concentrations after preeclampsia, highlighting the complex relationship between angiogenic biomarkers, preeclampsia, and later atherosclerotic burden.

来源:Acta Obstetricia et Gynecologica Scandinavica,查看原文。版权归原作者所有。

引用

  1. Acta Obstetricia et Gynecologica Scandinavica:Angiogenic biomarker concentrations and their relation to coronary atherosclerosis in women with a history of preeclampsia: Findings from the CPH‐PRECIOUS study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。